Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
essential tremor
Biotech
Biogen, Sage flunk midphase essential tremor trial, stop study
Sage Therapeutics and Biogen have extended the pharma industry’s multi-decade essential tremor losing streak.
Nick Paul Taylor
Jul 24, 2024 8:10am
Jazz's ph. 2 essential tremor test misses endpoint
Jun 20, 2024 9:30am
Cala Health expands tremor-treating wearable to Parkinson's
Jun 16, 2023 10:06am
Praxis share price halved by tremor fail but still plans phase 3
Mar 3, 2023 9:05am
Neurocrine axes essential tremor program on phase 2 data
Aug 5, 2022 4:53am
Cala Health nets $77M to expand on its tremor-fighting wearable
Nov 17, 2021 11:39am